Drug use surveillance of Takecab tablets for "Gastric ulcer, duodenal ulcer, and reflux esophagitis"

Trial Profile

Drug use surveillance of Takecab tablets for "Gastric ulcer, duodenal ulcer, and reflux esophagitis"

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Vonoprazan (Primary)
  • Indications Duodenal ulcer; Gastric ulcer; Reflux oesophagitis
  • Focus Adverse reactions
  • Sponsors Takeda
  • Most Recent Events

    • 14 Jun 2016 New trial record
    • 22 Mar 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top